GENETICS OF RECURRENT EARLY ONSET DEPRESSION (GENRED)
复发性早发性抑郁症的遗传学(GENRED)
基本信息
- 批准号:6041956
- 负责人:
- 金额:$ 29.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:bipolar depression clinical research data collection methodology /evaluation disease /disorder etiology disease /disorder onset family genetics gene expression genetic screening genetic susceptibility genotype human genetic material tag human subject interview linkage mapping major depression mental disorder diagnosis personality tests phenotype relapse /recurrence statistics /biometry
项目摘要
DESCRIPTION: (Adapted from investigator's abstract) Major depressive disorder
(MDD) has at least a 5-10% lifetime population prevalence and causes severe
morbidity and mortality including suicide. Heritability in twins is 0.4-0.70.
Mapping of susceptibility genes may be feasible with the recurrent, early-onset
subtype (MDD-RE) which demonstrates a three- to eight-fold increase in risk to
first-degree relatives of probands, vs. twofold for all MDD. The complex
pattern of transmission suggests multigenic transmission and/or locus
heterogeneity, so that large samples may be required. We propose a four-year,
six-site project to collect an estimated 770 pedigrees which contain 1,000
independent affected sibling pairs (ASPs), extended by first-degree
relationships to include additional affected relatives, plus unaffected
relatives (parents and sibs) for genetic phase information. All sites will have
identical inclusion criteria, clinical assessment DIGS and FIGS interviews and
the NEO personality inventory), interviewer training and reliability
monitoring, consensus diagnostic procedures, data management system, and
administrative oversight including a quality assurance program. Permanent cell
line specimens will be created and DNA extracted at the NIMH-sponsored cell
repository. A 10 cM genome scan will be completed on all affected subjects at
the Center for Inherited Disease Research (CIDR), which has approved this
project for CIDR access. A three-stage design is proposed: regions with maximum
lod scores (MLS) exceeding a liberal simulation-based threshold will be
identified in a genome scan of the affected individuals from the first half of
the sample, and candidate regions selected which continue to meet this
threshold after unaffected individuals are typed in these regions and added to
the analysis. Evidence for linkage in these regions will then be tested in the
entire sample with parametric and non-parametric analyses using stringent
simulation-based thresholds for 5% genome-wide significance. In the four-year
project period, genetic analyses can be completed on 80% of the sample (over
600 pedigrees, 800 ASPs), with the remaining families to be available by the
end of the project period for immediate completion of the genome scan on these
pedigrees at CIDR.
A timetable is proposed for rapid sharing of all biological materials, blinded
clinical data, genotypes and linkage analyses with the scientific community
through the NIMH-sponsored Center for Genetic Studies.
描述:(改编自研究者的摘要)重度抑郁症
(MDD) 在终生人口中的患病率至少为 5-10%,并会导致严重的
发病率和死亡率,包括自杀。双胞胎的遗传力为0.4-0.70。
对于复发性、早发型的疾病,绘制易感基因图谱可能是可行的
亚型(MDD-RE),其风险增加三到八倍
先证者的一级亲属,而所有 MDD 的一级亲属。综合体
传播模式表明多基因传播和/或多基因座
异质性,因此可能需要大样本。我们建议为期四年,
六个地点的项目,收集估计 770 个谱系图,其中包含 1,000 个谱系图
独立受影响的兄弟姐妹对 (ASP),按一级扩展
关系包括其他受影响的亲属以及未受影响的亲属
亲属(父母和兄弟姐妹)获取遗传阶段信息。所有站点都会有
相同的纳入标准、临床评估 DIGS 和 Figs 访谈以及
NEO 性格量表)、访谈员培训和可靠性
监测、共识诊断程序、数据管理系统,以及
行政监督,包括质量保证计划。永久细胞
将在 NIMH 赞助的细胞中制作细胞系样本并提取 DNA
存储库。所有受影响受试者的 10 cM 基因组扫描将于
遗传病研究中心 (CIDR) 已批准此
CIDR 访问项目。提出了三阶段设计:具有最大
lod 分数 (MLS) 超过基于自由模拟的阈值将
上半年受影响个体的基因组扫描中发现
样本和选择的候选区域继续满足此要求
在这些区域中输入未受影响的个体并将其添加到后的阈值
分析。这些区域之间联系的证据将在
使用严格的参数和非参数分析整个样本
基于模拟的 5% 全基因组显着性阈值。在这四年里
项目期间,可完成80%样本的遗传分析(超过
600 个血统,800 个 ASP),其余家族由
项目期结束后立即完成对这些基因组的扫描
CIDR的血统书。
提出了快速共享所有生物材料的时间表,盲法
临床数据、基因型以及与科学界的连锁分析
通过 NIMH 资助的基因研究中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE S ZUBENKO其他文献
GEORGE S ZUBENKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE S ZUBENKO', 18)}}的其他基金
GENETICS OF RECURRENT EARLY-ONSET DEPRESSION (GENRED)
复发性早发性抑郁症的遗传学(GENRED)
- 批准号:
6186938 - 财政年份:1999
- 资助金额:
$ 29.02万 - 项目类别:
GENETICS OF RECURRENT EARLY-ONSET DEPRESSION (GENRED)
复发性早发性抑郁症的遗传学(GENRED)
- 批准号:
6392700 - 财政年份:1999
- 资助金额:
$ 29.02万 - 项目类别:
BIOLOGICAL MARKERS FOR PRIMARY DEMENTIA IN ELDERLY
老年人原发性痴呆的生物标志物
- 批准号:
6221115 - 财政年份:1999
- 资助金额:
$ 29.02万 - 项目类别:
GENETICS OF RECURRENT EARLY-ONSET DEPRESSION (GENRED)
复发性早发性抑郁症的遗传学(GENRED)
- 批准号:
6528615 - 财政年份:1999
- 资助金额:
$ 29.02万 - 项目类别:
BIOLOGICAL MARKERS FOR PRIMARY DEMENTIA IN ELDERLY: ALZHEIMERS
老年人原发性痴呆的生物标志物:阿尔茨海默症
- 批准号:
6253471 - 财政年份:1997
- 资助金额:
$ 29.02万 - 项目类别:
PILOT--FUNCTIONAL CORRELATES OF SUBCORTICAL WHITE MATTER LESIONS
飞行员--皮层下白质病变的功能相关性
- 批准号:
6111628 - 财政年份:1996
- 资助金额:
$ 29.02万 - 项目类别:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
早发性复发性抑郁症的分子遗传学
- 批准号:
3388476 - 财政年份:1993
- 资助金额:
$ 29.02万 - 项目类别:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
早发性复发性抑郁症的分子遗传学
- 批准号:
2430938 - 财政年份:1993
- 资助金额:
$ 29.02万 - 项目类别:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
早发性复发性抑郁症的分子遗传学
- 批准号:
2248523 - 财政年份:1993
- 资助金额:
$ 29.02万 - 项目类别:
MOLECULAR GENETICS OF EARLY-ONSET RECURRENT DEPRESSION
早发性复发性抑郁症的分子遗传学
- 批准号:
2033906 - 财政年份:1993
- 资助金额:
$ 29.02万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 29.02万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 29.02万 - 项目类别: